-

Haug Partners Announces that Camille Turner and Kaitlin Abrams Have Been Elected to Become Partners in its New York City Office

NEW YORK--(BUSINESS WIRE)--Haug Partners LLP is excited to announce the elevations of Camille Turner and Kaitlin Abrams to Partner as of April 1, 2022.

Camille Turner’s work focuses on assisting clients develop and protect their intellectual property portfolios, including implementation and advocacy strategies for the enforcement of IP rights. Ms. Turner’s focuses her efforts in complex fields such as biotechnology, life sciences, and electronic commerce.

Ms. Turner received her undergraduate degree in Biological Sciences with a concentration in cellular and molecular biology from Northwestern University. She received her J.D. degree, magna cum laude from Loyola University Chicago School of Law where she was inducted into Alpha Sigma Nu Honor Society and was selected a Chicago Intellectual Property Colloquium Fellow. Ms. Turner currently serves as vice chair of the board and chair of the legal committee of Dance/NYC.

Kaitlin Abrams is an exceptional trial attorney whose practice focuses on intellectual property litigation and due diligence, in technical fields such as biotechnology life sciences, medical devices, and automotive systems and products. Ms. Abrams has extensive experience in all phases of litigation, from pre-suit investigation through trial and appeals.

Ms. Abrams received her J.D. degree from Notre Dame Law School and her undergraduate degree in Biological Sciences and Anthropology from Fordham University. Ms. Abrams was a recipient of the American Bar Association and Bloomberg BNA Award for Excellence in the Study of Intellectual Property Law in 2017 and served as an extern for the U.S. Patent and Trademark Office in the Office of Patent Legal Administration. Additionally during law school, Ms. Abrams served as President of the Women’s Legal Forum, of which now-Justice Amy Coney Barrett was the advisor.

Ed Haug, firm Chairman, noted that, “We could not be prouder of our own home trained associates Camille and Kaitlin. They have each demonstrated superior legal skills and work ethic that has greatly benefitted our clients, our partnership and the legal community. We look forward to a great future at the firm for both.”

Haug Partners LLP is a national law firm that provides integrated multidisciplinary legal services emphasizing all matters including intellectual property, antitrust, commercial litigation and trademarks. The firm has offices in Boston, New York City, Washington, D.C., and West Palm Beach.

Contacts

Media: Kyle Haug,  khaug@haugpartners.com, 212-588-0800

Haug Partners LLP


Release Versions

Contacts

Media: Kyle Haug,  khaug@haugpartners.com, 212-588-0800

More News From Haug Partners LLP

Haug Partners Congratulates Ralph Labaton on Elevation to Partner

NEW YORK--(BUSINESS WIRE)--Haug Partners LLP is excited to announce the elevation of Ralph Labaton to Partner as of January 1, 2024.. Ralph Labaton’s work focuses on antitrust litigation and other complex litigation matters. He has significant experience litigating class actions across multiple industries, including reverse payment and “pay-for-delay” pharmaceutical actions. Mr. Labaton also devotes his time to community efforts, including serving as a Member of the Young Professionals Committe...

Jennifer Patterson joins Haug Partners LLP’s Antitrust group

NEW YORK--(BUSINESS WIRE)--Haug Partners LLP is excited to welcome Jennifer Patterson as a partner in its New York office. Ms. Patterson has more than 25 years of experience handling antitrust litigation and other complex commercial disputes across a wide range of industries including pharmaceuticals, rail freight transportation, publishing, auto parts, aircraft parts, biometric identification, poultry breeding, food additives, pesticides, optical film, flat glass manufacturing, and accounting...

Haug Partners Successfully Defends Takeda’s Vyvanse® Patents At Trial Against Generic Challenge

NEW YORK--(BUSINESS WIRE)--On December 27, 2022, Haug Partners LLP and Gibbons PC obtained a key victory as to all counts for its client, plaintiffs Takeda Pharmaceutical Co. Ltd. and Takeda Pharmaceuticals U.S.A., Inc., defeating a generic challenge by Norwich Pharmaceuticals Inc. to Takeda’s Orange Book-listed patents for Takeda’s multibillion dollar Vyvanse® product. In a 107-page Opinion, Judge Stanley R. Chesler (D.N.J.) found that Takeda prevailed on all fourteen asserted claims in the ma...
Back to Newsroom